Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e459aef6422b70b72977725605d0ce2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1485916c484c93c388cb9f463fc94b2d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3069 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2013-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_587b979588324daa502973418be68e22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d17638c2bcccfb508fdb9869cc7460f1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef061949e330a771cb0afe9936e50e1e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb1f7058d8d2ee93ea0330953f3fe09b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44cd2279517ac380f00de5b3c17180fa |
publicationDate |
2015-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20150085508-A |
titleOfInvention |
Method for enhancing specific immunotherapies in cancer treatment |
abstract |
The methods and compositions of the present invention are directed to enhancing specific immunotherapy in cancer therapy. In particular, aspects of the invention relate to novel approaches for enhancing immune function using a complex carbohydrate pharmaceutical compound alone or in combination with other targeted immunotherapy to increase the efficacy of cancer immunotherapy. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019151712-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190094710-A |
priorityDate |
2012-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |